Medical Marijuana News Channel

Medical Marijuana News Channel

Thursday, January 1, 2015

Medicinal cannabis: delaying the inevitable?













Opponents of medicinal cannabis argue that there are already several cannabinoid medicines which are legally registered for multiple sclerosis, chemotherapy-induced nausea and vomiting, and AIDS-related weight loss patients who need them. This is simply not true.
Nabiximols (Sativex) is only approved (for use for a short period) for one condition (stiffness due to multiple sclerosis). Even for patients who satisfy the stringent criteria it is more available in theory than practise. If available and approved for other indications, the likely cost ($800/month) will prevent all but the wealthiest using the drug. Older cannabinoid medicines such as Dronabinol were hardly used. They were slowly and unpredictably absorbed and therefore difficult to use.

It’s usual to start new treatments on a small scale and maybe expand later if a case can be made for expansion. But we should start with the conditions where the evidence for far greater benefit than risk is already clear.

When used medicinally, studies show that cannabis is often effective in relieving distressing symptoms in a number of conditions while the side effects are minimal. It is wrong to draw conclusions about side effects of cannabis from studies of recreational cannabis just as it would be wrong to assess the safety of regulated alcohol from studies of bootleg liquor.

People with advanced cancer and parents of children with rare and intractable forms of childhood epilepsy have recently begun to brave the media to discuss how medicinal cannabis had helped them and their families. They have testified that the symptoms of these diseases and the side effects of the treatments have been much worse than any side effects of medicinal cannabis. The question should not be whether medicinal cannabis is usually more effective then conventional medications but whether patients should be able to benefit from cannabis if the conventional medications have been tried and failed.

More than two-thirds of Australians support the use of medicinal cannabis because they see this as a compassionate approach to suffering patients. Almost three-quarters of Australians believe we should be doing more research on medicinal cannabis. At present, getting funding, official approval and supplies of medicinal cannabis in order to carry out scientific research is almost impossible. Very few studies of medicinal cannabis have been carried out in Australia or the US.

Story Source: The above story is based on materials provided by THEAGE
Note: Materials may be edited for content and length
Click here to read more

No comments:

Post a Comment